Ryan Black

Synjardy XR, a combination of empagliflozin and metformin hydrochloride, was approved this afternoon by the FDA for glucose management in type 2 diabetics. The drug is a collaboration between Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company.

Regeneron and Sanofi’s highly-anticipated atopic dermatitis drug dupilumab, trade name Dupixent, has been accepted by the European Medicines Agency (EMA) for review. The drug has performed well in trials and is considered an impending blockbuster.

A study out of the University of Pittsburgh identifies significant comorbidity and negative outcomes in those with insomnia and asthma, and finds that even asthmatics who report no nighttime breathing disturbances still face a predisposition to sleeplessness.

Vicki Lawrence, the Carol Burnett Show actress and singer behind "The Night the Lights Went Out in Georgia," recently became a spokeswoman for a sponsored chronic idiopathic urticaria resource, and spoke in a new interview about the self-blame associated with skin diseases.

Age-related macular degeneration, the leading cause of blindness in the developed world, has long been linked to diet and obesity. Recently, we came closer to understanding just exactly why that is.

A recent study joins an ever-deepening well of data about the health benefits of the Mediterranean diet, including its risk-reduction potential for age-related macular degeneration. AMD is the leading cause of blindness in the developed world.

As if egg-laying Australian mammals with webbed feet weren't fascinating enough, it turns out that their venom contains an insulin-stimulating peptide resistant to the forces that usually shorten its effectiveness in humans. Yes, they have venom.

Santen Pharmaceutical Co., Ltd. today announced topline results from a phase 3 trial of Opsiria, a sirolimus injection intended to treat non-infectious posterior uveitis.

Though air pollution has previously been associated with elevated rates of atopic dermatitis (AD), the reason for that correlation remained mostly a mystery until last week.

After a newspaper report found that less than 10 of Tennessee's thousands of HCV-positive prisoners were receiving treatment, two inmates sued the state. Now, prison officials are seeking a bit more help in battling the disease.

A new study of inner city schools found evidence that high levels of mouse allergens correlated with hindered lung function and an increase in sick days caused by asthma symptoms.

Novo Nordisk’s Xultophy combines a previously marketed basal insulin with a glucagon-like peptide-1 receptor agonist, and was yesterday accepted by the FDA. The company plans to have the drug on the market in 2017.

A recent study found that Puerto Rican children who lived closer to major roadways exhibited higher levels of certain inflammation-related cytokines in their blood.

Despite a heightened risk of diabetes, Asian Americans are least likely to be screened for the disease, according to a new study from the University of Chicago.

Bryan Bickell, a three-time Stanley Cup winner, has turned to former goalie Josh Harding for guidance on how his new diagnosis will impact his life and career. Harding continued to play in the league for two seasons following his own multiple sclerosis diagnosis in 2012.

In a study announced at the 2016 American College of Rheumatology Annual Meeting in Washington, DC, lupus patients with less education were also likely to wait longer for referral to a specialist.

“This is a subset of the RA population that we should probably give intensive treatment to," Dr. Harrold says of RA patients diagnosed with certain prognosis factors. "Not only clinical adverse sequelae, but also in their social environment, like being able to work or function.”

The once-daily vaginal insert was found safe and effective in reducing vulvar and vaginal atrophy pain from intercourse. This is the first drug appoved by the FDA that contains its active ingredient, dehydroepiandrosterone.

Asked to assume equal cost-effectiveness, the patients were given eight facets of treatment and asked to rank them between 1 and 8, with 1 being the most important to them and 8 being the least.

A research team from the University of Delaware sought to see how much strength one would need, how fast they needed to walk, and how far they needed to walk to achieve a sufficient 6,000 steps in a day, and found that most knee OA patients surpassed their thresholds.

With extensive literature review and expert input, the ACR and the American Association of Hip and Knee Surgeons (AAHKS) have come together to propose a set of guidelines for medication during the perioperative period for patients undergoing knee or hip arthroplasty.

Used for treatment of inflammation in rheumatic diseases, glucocorticoids are known to cause osteoporosis. The American College of Rheumatology has put forth new recommendations to hopefully decrease the frequency of bone fractures.

Prescribing rheumatologists discussed drug interactions, costs, contraindications, and severity of side effects with less than 50% of the patients in the study to whom they had prescribed disease-modifying antirheumatic drugs.

With ever-growing data that the inflammation in rheumatic conditions can go hand-in-hand with cardiovascular inflammation, two different studies seek to broaden rheumatology’s approach to dangerous conditions it may influence.

Speaking at ACR 2016, the current chair of the Spondyloarthritis Research and Treatment Network (SPARTAN) presented data that showed that a combination of inflammatory drugs may inhibit ankylosis, the painful fusion of bones.

A new study out of Ireland examined the prevalence of extra-articular manifestations in axial spondyloarthritis, and found that women were at significantly higher risk for inflammatory bowel disease and uveitis than men.

A report out of Cedars-Sinai Medical Center shows a reduction in hip disease progression in ankylosing spondylitis patients who receive anti-tumor necrotics factor treatment.

Certain types of inflammation go hand-in-hand. Columbia University researchers hypothesized that treatment that lowered arthritis disease activity would also decrease the risk of heart failure.

Donald Trump got elected, in part, by pledging to dismantle the Affordable Care Act. So why did it set a record for sign-ups the day after the Trump victory?

The common multiple sclerosis treatment, according to a study out of Duke, may do very little for as many as half of people with the disease. In a mouse model of MS, they identified different disease pathways in those resistant to the treatment, raising questions about the heterogeneity of MS.